The Mental Health Timeline Every Woman Should Know

From the first period through pregnancy, parenting, menopause, and later life, symptoms can change with biology and circumstance. This calm timeline shows what to notice, what not to assume, and when to seek urgent help.

What this guide covers — and what it deliberately does not. It covers the lifespan map and navigation path across puberty, menstrual years, reproductive events, caregiving, menopause, and later life. It gives brief signals, evaluation questions, and urgent boundaries. It deliberately does not repeat the diagnostic criteria, treatment comparisons, medication details, or safety planning owned by Articles A01–A09; those pages are linked where the detail belongs.

Zoom

A map, not a forecast

You may look back and see chapters that seemed unrelated. Your first period arrived during school pressure. A pregnancy changed sleep and relationships. Years later, hot flashes appeared while you were caring for a parent.

It is tempting to draw one straight hormone line through the story. Human lives are rarely that simple.

A life stage is context, not a diagnosis. Puberty, reproductive events, caregiving, menopause, and aging can change vulnerability without deciding who becomes mentally ill.[1–4] Hormonal changes and social changes often arrive together. Research cannot always separate them cleanly.

This map also does not describe one required route. Not every woman menstruates, uses contraception, becomes pregnant, parents, or reaches each stage in the same order. Some transgender and nonbinary people share reproductive experiences discussed here. Studies often enrolled cisgender women, so the evidence population must stay visible.

Use the map to notice timing, function, and safety. Do not use it to predict your future or score your risk.

Population risk and personal risk are different. A study may compare thousands of people and find a higher average rate in one group. It still cannot tell whether one reader will develop a disorder. The people studied may also differ in age, health, income, exposure to violence, or access to care. Those limits belong beside the finding, not hidden at the end.

Hormonal sensitivity is not the same as an abnormal hormone level. Some people appear more sensitive to normal change. Others have symptoms for reasons that are not mainly hormonal. One blood draw cannot show which pathway caused anxiety, low mood, poor sleep, or foggy thinking. A result may guide a medical question without settling a psychiatric one.

Sequence also matters. A hot flash may wake someone, then worry keeps her awake. A shift schedule may cause sleep loss during the same month that cycles change. A partner may become controlling during pregnancy. The events can interact without one being the sole cause. Good care asks what changed first, what followed, and what is still happening.

Think of the timeline as a set of date stamps, not a verdict. Write down the first clear change, the next change, and the effect on daily life. Leave room for more than one cause. A useful map can hold “my cycle shifted,” “my mother became ill,” and “I began a new medicine” at the same time. It can also show that one symptom improved while another did not. That detail helps a clinician test ideas instead of forcing one neat story.

Use urgent or emergency help now when safety cannot wait. If you may act on suicidal thoughts, have a plan or access to lethal means, cannot stay safe, or may harm someone, call 911 or go to an emergency department. In the United States, call or text 988 for crisis support.[5] After childbirth, severe sleeplessness with unusual energy, confusion, paranoia, hallucinations, unusual beliefs, or rapidly changing behavior can signal postpartum mania or psychosis. Keep the parent with a responsible adult, place the infant with another responsible adult, and do not ask the affected parent to drive while arranging emergency care.[2,6] At any stage, sudden or fluctuating confusion, new one-sided weakness, facial droop, trouble speaking, seizure, collapse, or an abrupt loss of function needs urgent medical assessment—not a menopause, depression, or dementia label.[7,8]

These instructions come first because a timeline should never delay care. The rest of this page is for pattern recognition and preparation.

What can follow you across stages

The same symptom can mean different things at different times. Poor concentration may reflect depression, anxiety, ADHD, trauma, pain, sleep loss, medication effects, anemia, thyroid illness, or a demanding week. Timing helps, but timing alone does not diagnose the cause.

Course gives useful clues. A lifelong pattern differs from a new change after illness. A symptom that appears only before a period differs from one that remains all month. Little sleep with exhaustion differs from little sleep with unusual energy. A slow memory change differs from confusion that began this morning. These contrasts guide the next questions; none makes a diagnosis alone.

Function should be specific. “I am doing okay” may mean the bills are paid while meals, friendships, exercise, or joy have vanished. Ask what is harder, what takes longer, what is being avoided, and what feels unsafe. A person does not need to lose every role before care is appropriate.

Visible success can also hide distress. “High-functioning anxiety” and “high-functioning depression” are descriptions, not formal diagnoses. A person can keep working or parenting while sleep, joy, relationships, and safety are slipping. The guide to hidden anxiety and depression explains how clinicians assess the cost and sustainability of functioning.[9]

ADHD can be recognized later in girls and women, but a hormone story cannot confirm it. Adult assessment still needs a developmental history, impairment, and effects across more than one area of life. New or episodic attention problems also need other explanations considered. The adult ADHD assessment guide owns that evaluation.[10]

Trauma exposure is not the same as PTSD, and coping patterns do not prove a hidden history. A longitudinal assessment asks what happened, when symptoms began, where they appear, and what else fits. See the trauma-versus-personality guide for that boundary.[11]

Relationship distress also needs a safety lens. Attachment labels cannot excuse stalking, coercive control, sexual violence, reproductive coercion, or physical harm. The relationship-patterns and abuse-safety guide separates difficult cycles from abuse.[12]

Finally, “tired” is not one diagnosis. Insomnia, limited sleep opportunity, sleep apnea, restless legs, circadian timing, medicines, pain, and mood episodes require different care. The women’s sleep-disorders guide owns that differential.[13]

Across every stage, access changes the picture. Racism, disability barriers, LGBTQ+ stigma, poverty, rural distance, immigration concerns, unsafe relationships, and medical dismissal can affect exposure and care. A personal timeline is therefore both biological and social.

Screening is one doorway, not the room. A score can flag symptoms and help track change. It cannot decide whether the cause is depression, bipolar disorder, trauma, a sleep disorder, substance use, pain, a medical condition, or several problems together. A useful screening program has a safe next step for assessment and follow-up.

Evidence gaps matter, too. Many studies leave out people with disabilities, unstable housing, limited English, complex illness, or gender-diverse identities. Rural and low-resource settings may have very different care paths. When evidence is thin, the honest response is more careful wording and shared decisions—not pretending the person is unusual or the symptom is unreal.

Puberty and the first period

Normal puberty should not be treated as disease. Irritability, a need for privacy, changing sleep, or a hard week is not a diagnosis by itself. Concern rises with a marked and lasting change, major impairment, medical instability, or danger.

Family and school support can be practical. Ask about safety, meals, pain, sleep, online harassment, attendance, trusted adults, and what changed. Do not turn every emotion into “hormones,” especially when abuse, discrimination, neurodevelopmental needs, or an eating disorder may be present.

Puberty and first menstruation

Body, sleep, identity, peer, school, and family changes may arrive together. Earlier menarche is associated with depression in pooled observational research, but that cannot prove the timing caused one person’s symptoms.[14] Consider evaluation for persistent withdrawal, lost interest, major anxiety, eating restriction, bingeing or purging, bullying, abuse, substance use, self-harm, or falling function. Support should protect privacy while involving safe adults. The women and adult ADHD guide explains why quieter attention problems may be missed.

Menstrual years, cycle-linked symptoms, and contraception

Contraceptive counseling should be voluntary and centered on the person’s goals. A method can be allowed under population guidance yet still be a poor fit for one person. A history of depression is not a reason to remove every option.

Reproductive years and menstrual cycling

Some people notice mild cycle-linked shifts; many do not. Useful evaluation starts with timing, baseline symptoms, pregnancy possibility, pain, sleep, substances, medicines, thyroid or iron concerns, and function. A daily record can show whether symptoms cluster around one cycle phase or continue throughout the month. It cannot diagnose the cause alone. For a focused explanation and an authorized tracking approach, use the menstrual-cycle and mood guide.

PMS, PMDD, and premenstrual exacerbation

Premenstrual worsening is not automatically PMDD. Symptoms that remain present across the month may be premenstrual exacerbation of another disorder. Prospective daily tracking across cycles helps distinguish the pattern and its impact.[15,16] Severe suicidal symptoms need immediate assessment regardless of cycle day; do not wait for bleeding. The PMDD, PMS, and PME owner page covers diagnostic timing and treatment choices without relying on one retrospective month.

Contraception and psychiatric medications

Hormonal contraception is neither a universal cause nor cure for depression. U.S. guidance generally places depressive disorders in the no-restriction category for major methods, while the research on mood remains mixed and product-specific.[17,18] Review the exact method, timing, indication, interactions, past response, and reproductive goals. Do not dismiss a clear personal change, and do not assume causation from timing alone. For psychiatric medicines around pregnancy planning, use the perinatal medication and diagnosis guide.

PCOS, endometriosis, fertility, and pregnancy loss

Do not force stages of grief or a positive lesson after fertility treatment or loss. Ask what the experience meant, what support is welcome, and whether follow-up is reachable. Someone may need medical facts, quiet, ritual, therapy, workplace help, or several of these.

PCOS and endometriosis

PCOS is associated with higher depression, anxiety, and eating-disorder burden, so screening and follow-up can help; these outcomes are not inevitable.[19] Endometriosis is also associated with distress and reduced quality of life, but its pain is not “all psychological,” and association does not prove one direct psychiatric cause.[20,21] Care should address physical symptoms, pain, metabolic or reproductive needs, stigma, and mental health together. If symptoms have a separate cycle-linked pattern, the PMDD and PME guide explains what to track.

Fertility challenges and treatment

Fertility care can add uncertainty, procedures, cost, waiting, relationship strain, and unwanted public questions. Psychological support may modestly reduce distress, but it cannot guarantee pregnancy or prove that stress caused infertility.[22,23] Evaluation may include mood, anxiety, trauma, sleep, treatment effects, relationship safety, finances, culture, and prior loss. Support is worthwhile because distress matters, not because someone must become calm enough to conceive. The hidden-distress guide can help when appointments continue while private strain grows.

Pregnancy loss and grief

Pregnancy-loss grief has no required timetable, and gestational age does not measure its legitimacy. Anxiety and depression are higher for some people after loss, and some studies also report trauma symptoms, while grief itself is not automatically a disorder.[24] Evaluation should include medical recovery, culture, prior history, support, function, and the experience of partners or non-gestational parents. Heavy bleeding, severe pain, fainting, fever, psychosis, or suicidal intent needs urgent care. The perinatal mental-health guide explains when grief and a treatable disorder may overlap.

Preconception and pregnancy

Medical and psychiatric symptoms can overlap. Severe headache, vision change, chest pain, breathing trouble, seizure, fainting, fever, heavy bleeding, or focal neurologic change needs prompt or emergency obstetric assessment.[8] “Anxiety” should not close a medical evaluation.

Preconception planning

Preconception is a chance to plan, not a command to become medication-free. Review prior episodes, relapse and withdrawal risks, the exact medicines and supplements, sleep, substances, medical conditions, safety, and available support.[25] Some changes require time, contraception during adjustment, or specialist input. Do not abruptly stop psychiatric medication because pregnancy is planned or possible. The perinatal diagnosis and medication guide owns medicine-specific pregnancy and lactation boundaries.

Pregnancy

Pregnancy does not protect someone from depression, anxiety, OCD, bipolar disorder, trauma symptoms, substance problems, or violence. Screening should recur during pregnancy and postpartum and connect to assessment, treatment or referral, and follow-up; a positive screen is not a diagnosis.[2] Before medication for presumed depression or anxiety, the history should be checked for mania and hypomania. Needed treatment should not be withheld or stopped solely because of pregnancy or lactation status.[26] Use the perinatal guide for the full differential.

Postpartum and the first year

An unwanted intrusive thought is not automatically an intention. Clinicians ask whether it is unwanted, feared, resisted, believed, commanded, planned, or linked with loss of control. That distinction can separate anxiety or OCD from psychosis and imminent danger. It should never be guessed from one sentence.

Severe sleeplessness with unusual energy, confusion, paranoia, hallucinations, unusual beliefs, or marked activation is an emergency, not ordinary newborn exhaustion.[2,6] Keep the parent and infant supported while emergency care is arranged. The women’s sleep guide explains routine sleep problems only after emergencies are excluded.

Postpartum and the first year after birth

Recovery, feeding, sleep, identity, relationships, and practical demands differ widely. Baby blues, depression, anxiety, OCD, trauma, bipolar episodes, and psychosis are not interchangeable. Symptoms can also emerge later: in a seven-state follow-up, 7.2% screened positive at 9–10 months, and 57.4% of that group had not screened positive at 2–6 months.[27] These were screening results, not diagnoses or national rates. Use the postpartum disorders guide for distinctions and urgent action.

Parenting, caregiving, work, and relationships

If fear, monitoring, coercive control, sexual pressure, threats, or violence is present, chore negotiation may be unsafe. Use the relationship-patterns and abuse-safety guide privately and on a safer device when possible.[12]

If you fear losing control or cannot supervise safely, hand care to a sober, responsible adult now. Imminent harm, psychosis, intoxication, or an unsafe child requires emergency help, not a completed self-care list.

Parenting, caregiving, work, and relationship transitions

Parenting and caregiving stress is shaped by workload, money, leave, childcare, disability, isolation, sleep, and work conditions—not simply resilience or self-care.[28,29] Evaluation can separate role-specific exhaustion from depression, anxiety, trauma, sensory distress, substance use, unsafe relationships, and unmet material needs. Support may mean a clinical visit, safer handoff, respite, workplace change, money or housing help, or a fairer workload. The maternal burnout and sensory-overload guide owns that distinction.

Perimenopause, menopause, and POI

Perimenopause

Cycle changes, hot flashes, sleep problems, mood symptoms, and social transitions may overlap. Population evidence suggests depression vulnerability rises for some people during perimenopause, but most do not develop major depression, and the association does not prove one hormone cause.[30] Evaluation should consider prior mood history, pregnancy, PMDD or PME, sleep apnea, restless legs, thyroid or iron problems, pain, medicines, substances, and bleeding. The perimenopause mental-health guide owns the full evaluation.

Menopause and postmenopause

Menopause is one point in reproductive aging; postmenopause is not a permanently high-risk psychiatric state. Mood, sleep, hot flashes, pain, relationships, work, grief, and health changes may still interact. MHT decisions are individualized by symptoms, age and timing, route, formulation, uterine status, bleeding, and medical history. It is not a universal antidepressant. The perimenopause and menopause guide explains benefits, limits, alternatives, and when targeted testing helps.

Early, surgical, or medically induced menopause and POI

Premature ovarian insufficiency, ovarian surgery, and cancer treatment can create abrupt symptoms, fertility loss, sexual concerns, and long-term bone or cardiovascular needs. Their context is not the same as natural menopause near the usual age. POI needs specialist evaluation, and diagnostic testing differs across guidelines.[31] Hormone options also change with age, cause, uterine status, and contraindications. The perimenopause owner page separates these pathways from routine midlife assumptions.

The 2026 FDA boundary

One regulatory boundary deserves plain language. On February 12, 2026, FDA approved removal of specified cardiovascular, breast-cancer, and probable-dementia boxed-warning statements for six products: Prometrium, Divigel, Cenestin, Enjuvia, Estring, and Bijuva.[32,33] The action did not cover every MHT product, erase all risks, or create a dementia-prevention indication.

MHT can treat appropriate menopause symptoms. It should not be used solely to prevent dementia or other chronic conditions.[3,34] The exact current label for the exact product still controls.

Later life and cognitive change

Later life

Grief, isolation, chronic illness, pain, sleep apnea, sensory loss, caregiving, falls, medication burden, alcohol, and cognitive change can overlap. Depression is not normal aging.[4] Evaluation should ask what changed, how quickly, what daily functions changed, and which medicines or substances may contribute. Social isolation, age-related medicine risks, and alcohol interactions are meaningful and potentially modifiable.[35–37] For persistent sleepiness, snoring, or fragmented sleep, use the women’s sleep-disorders guide.

Gradual change versus urgent change

Gradual forgetfulness is different from sudden confusion. A careful evaluation may review depression, grief, sleep, hearing and vision, pain, medication effects, alcohol, infection, metabolic illness, stroke risk, and cognitive trajectory.[38] Family or another trusted person may add observations when the patient agrees.

The U.S. Preventive Services Task Force found insufficient evidence for routine cognitive screening in community-dwelling adults 65 or older who have no recognized symptoms.[39] That statement does not mean symptoms should be ignored. It does not apply to sudden change.

Sudden or fluctuating confusion, abrupt loss of function, new weakness, speech trouble, collapse, head injury, or inability to awaken needs urgent medical assessment.[7] Do not label it depression, menopause, normal aging, or dementia from a distance.

The accessible lifespan timeline

The table below is the complete text alternative for the companion visual. It has no arrow suggesting that one stage causes the next—or that any stage causes mental illness. The three columns after each stage act as the labels common transition, consider evaluation, and urgent help.[1–4,7]

Caption: Life stages can change context and population risk, but they do not determine one person’s diagnosis. Notice patterns, ask for evaluation when symptoms persist or impair life, and use urgent care for safety, psychosis, sudden medical change, or inability to function safely.[1–4,7]

How to prepare for an evaluation

Bring a timeline, not a theory. Start with the most important change and when it began. Note whether it is constant, episodic, cycle-linked, linked to a reproductive event, or tied to sleep, pain, medication, substance use, stress, or safety.

Four short questions can organize the visit. What changed? When did it start? Where does it show up? What does it cost? Add what improves it, what worsens it, and what you fear may be missed. This keeps the story broad enough for a differential while giving the clinician a clear place to begin.

You do not need perfect dates. “Before the new job,” “two cycles after the medicine changed,” or “within days of birth” can still help. If numbers feel hard, bring three real examples. One might come from home, one from work, and one from sleep or safety. Concrete moments are often easier to assess than a long list of labels.

Describe function across several areas. Work may look intact while eating, sleep, parenting, money, driving, or relationships are becoming unsafe. Tell the clinician what the effort costs and what has disappeared from life.

Bring an exact list of prescriptions, over-the-counter medicines, hormones, supplements, alcohol, cannabis, nicotine, and other substances. Include dose, timing, recent changes, benefit, and unwanted effects. Do not stop a psychiatric medicine or hormone abruptly to make the timeline “clean.”

Ask what else needs consideration. Depending on the history, that may include depression, anxiety, OCD, bipolar disorder, psychosis, ADHD, autism, trauma, eating disorders, substance use, sleep disorders, pain, pregnancy, thyroid disease, anemia or iron problems, infection, medication effects, and neurologic illness.

A screen can organize symptoms. It cannot finish the diagnosis. A useful plan says what happens after the result: further assessment, treatment, referral, follow-up, or urgent action.

Ask how uncertainty will be handled. A sound plan can say, “We do not know yet, so we will check these two possibilities and review in two weeks.” It should also name what change would move the visit sooner. Uncertainty is safer when it has a next step.

If communication, hearing, language, disability, transportation, childcare, or cost makes care harder, say so early. Ask about an interpreter, telehealth, an accessible room, a support person, or a shorter first task. With consent, a trusted person may help describe change over time. They should not replace the patient’s voice.

If you track sensitive information, protect it. A printed or local-only record on a device you control is safer than an unreviewed web form. If another person monitors your phone or accounts, use a safer device or do not save the details. Tracking must never delay emergency care.

Three common mistakes to avoid

The first mistake is turning an association into destiny. A group may show higher average risk during a transition. That does not predict who will become ill, prove one cause, or set a personal deadline.

Relative numbers can sound larger than the lived difference. Ask who was studied, what outcome was measured, and what the starting risk was. Also ask whether the result came from a diagnosis, a screening score, or self-reported symptoms. Those are not interchangeable.

The second is treating every change as hormonal. Reproductive changes can matter, but so can sleep, grief, pain, violence, discrimination, medication, substance use, illness, work, money, and care access. A “normal” hormone result does not erase symptoms. An unusual result does not diagnose a psychiatric cause.

A lab result is one piece of time. Levels can vary, and many tests answer a narrow medical question. Be cautious when a commercial panel claims to reveal the single cause of mood, weight, focus, sleep, and relationships. One neat label can hide several treatable problems.

The third is making a treatment change before defining the problem. Contraception, psychiatric medication, and MHT have different indications, risks, interactions, and evidence. Pregnancy, lactation, uterine status, age, timing, and medical history can change decisions. Shared planning is safer than a universal rule.

Abrupt changes can also bring withdrawal, relapse, sleep loss, or a return of symptoms. A prescriber can help weigh the risk of the medicine against the risk of untreated illness. The safest plan is tied to the exact drug, dose, goal, and stage—not to the word “hormone” or “pregnant” alone.

If you remember one thing

A life stage can change the questions worth asking. It does not write the answer.

Notice timing, function, context, and safety. Ask for an evaluation when symptoms persist, recur, or narrow your life. Use emergency care for suicidal danger, psychosis or mania, postpartum activation, sudden confusion, focal neurologic change, severe medical symptoms, or inability to keep someone safe.

You do not need a perfect hormone story—or a complete life timeline—to deserve careful care. The next useful step can begin with one honest change.

The rest of this series

Ten guides on women’s mental health, written to be read in any order. Each one owns its own question, so none of them repeats another.

• You are here: Start with the map: The Mental Health Timeline Every Woman Should Know
• PMDD, PMS, and premenstrual exacerbation
• Postpartum depression, anxiety, OCD, and psychosis warning signs
• Maternal burnout, depression, and sensory overload
• Perimenopause: anxiety, mood, and brain fog
• Hidden anxiety and depression behind outward success
• When adult ADHD looks like anxiety or depression
• Women, anxiety, hormones, insomnia, and sleep disorders
• Trauma or personality? Understanding adult patterns
• Repeating relationship patterns: attachment, trauma, and online labels

Education disclaimer

This article is for general education. It cannot diagnose you, replace an evaluation, or give personal medical advice. Reading NPFady.com does not create a clinician-patient relationship. Do not start, stop, or change medication or hormone treatment without the clinician who knows your history.

References

1. World Health Organization. Mental health of adolescents. Fact sheet. September 1, 2025. https://www.who.int/news-room/fact-sheets/detail/adolescent-mental-health. Accessed 2026-08-15.
2. American College of Obstetricians and Gynecologists. Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum: Clinical Practice Guideline No. 4. Obstet Gynecol. 2023;141(6):1232–1261. doi:10.1097/AOG.0000000000005200. PMID 37486660. https://pubmed.ncbi.nlm.nih.gov/37486660/
3. National Institute for Health and Care Excellence. Menopause: Identification and Management (NG23). Updated 2024. https://www.nice.org.uk/guidance/ng23/chapter/recommendations. Accessed 2026-08-15.
4. National Institute on Aging. Depression and Older Adults. Updated 2025. https://www.nia.nih.gov/health/mental-and-emotional-health/depression-and-older-adults. Accessed 2026-08-15.
5. 988 Suicide & Crisis Lifeline. Get Help. https://988lifeline.org/get-help/. Accessed 2026-08-15.
6. National Institute for Health and Care Excellence. Antenatal and Postnatal Mental Health: Clinical Management and Service Guidance (CG192). https://www.nice.org.uk/guidance/cg192/chapter/recommendations. Accessed 2026-08-15.
7. National Institute for Health and Care Excellence. Delirium: Prevention, Diagnosis and Management (CG103). Updated 2023. https://www.nice.org.uk/guidance/cg103/chapter/Recommendations. Accessed 2026-08-15.
8. Centers for Disease Control and Prevention. Urgent Maternal Warning Signs. Hear Her Campaign. https://www.cdc.gov/hearher/maternal-warning-signs/index.html. Accessed 2026-08-15.
9. National Institute of Mental Health. Depression. https://www.nimh.nih.gov/health/publications/depression. Accessed 2026-08-15.
10. Centers for Disease Control and Prevention. ADHD in Adults. https://www.cdc.gov/adhd/about/adhd-in-adults.html. Accessed 2026-08-15.
11. Department of Veterans Affairs and Department of Defense. Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder. Version 4.0. 2023. https://www.healthquality.va.gov/guidelines/mh/ptsd/. Accessed 2026-08-15.
12. Centers for Disease Control and Prevention. About Intimate Partner Violence. https://www.cdc.gov/intimate-partner-violence/about/index.html. Accessed 2026-08-15.
13. Department of Veterans Affairs and Department of Defense. Clinical Practice Guideline for Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea. Version 3.0. 2025. https://www.healthquality.va.gov/guidelines/CD/insomnia/index.asp. Accessed 2026-08-15.
14. Ghadirzadeh E, Moosazadeh M, Shakeriastani K, et al. The association between age at menarche and depression: A systematic review and meta-analysis with meta-regression. Clinics (Sao Paulo). 2025;80:100695. doi:10.1016/j.clinsp.2025.100695. PMID 40412096. PMCID PMC12148817. https://pmc.ncbi.nlm.nih.gov/articles/PMC12148817/
15. American College of Obstetricians and Gynecologists. Management of Premenstrual Disorders: Clinical Practice Guideline No. 7. Obstet Gynecol. 2023;142(6):1516–1533. doi:10.1097/AOG.0000000000005426. PMID 37973069. https://pubmed.ncbi.nlm.nih.gov/37973069/
16. O’Brien PMS, et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health. 2011;14(1):13–21. doi:10.1007/s00737-010-0201-3. PMID 21225438. PMCID PMC4134928. https://pmc.ncbi.nlm.nih.gov/articles/PMC4134928/
17. Nguyen AT, Curtis KM, Tepper NK, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep. 2024;73(4):1–126. doi:10.15585/mmwr.rr7304a1. PMID 39106314. PMCID PMC11315372. https://www.cdc.gov/mmwr/volumes/73/rr/rr7304a1.htm
18. Kraft MZ, Rojczyk P, Weiss T, et al. Symptoms of mental disorders and oral contraception use: A systematic review and meta-analysis. Front Neuroendocrinol. 2024;72:101111. doi:10.1016/j.yfrne.2023.101111. PMID 37967755. https://pubmed.ncbi.nlm.nih.gov/37967755/
19. Teede HJ, Tay CT, Laven JJE, et al.; International PCOS Network. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of PCOS. Hum Reprod. 2023;38(9):1655–1679. doi:10.1093/humrep/dead156. PMID 37580037. PMCID PMC10477934. https://pmc.ncbi.nlm.nih.gov/articles/PMC10477934/
20. Becker CM, Bokor A, Heikinheimo O, et al.; ESHRE Endometriosis Guideline Group. ESHRE guideline: endometriosis. Hum Reprod Open. 2022;2022(2):hoac009. doi:10.1093/hropen/hoac009. PMID 35350465. PMCID PMC8951218. https://pmc.ncbi.nlm.nih.gov/articles/PMC8951218/
21. Szypłowska M, Tarkowski R, Kułak K. The impact of endometriosis on depressive and anxiety symptoms and quality of life: a systematic review. Front Public Health. 2023;11:1230303. doi:10.3389/fpubh.2023.1230303. PMID 37744486. PMCID PMC10512020. https://pmc.ncbi.nlm.nih.gov/articles/PMC10512020/
22. Gameiro S, Boivin J, Dancet E, et al. ESHRE guideline: routine psychosocial care in infertility and medically assisted reproduction—a guide for fertility staff. Hum Reprod. 2015;30(11):2476–2485. doi:10.1093/humrep/dev177. PMID 26345684. https://academic.oup.com/humrep/article/30/11/2476/2384614. Official full guideline: https://www.eshre.eu/-/media/sitecore-files/Guidelines/Psychology/ESHRE-psychology-guideline_2015_final_version-1_2.pdf. Accessed 2026-08-15.
23. Dube L, Bright K, Hayden KA, Gordon JL. Efficacy of psychological interventions for mental health and pregnancy rates among individuals with infertility: a systematic review and meta-analysis. Hum Reprod Update. 2023;29(1):71–94. doi:10.1093/humupd/dmac034. PMID 36191078. https://pubmed.ncbi.nlm.nih.gov/36191078/
24. Herbert D, Young K, Pietrusińska M, MacBeth A. The mental health impact of perinatal loss: A systematic review and meta-analysis. J Affect Disord. 2022;297:118–129. doi:10.1016/j.jad.2021.10.026. PMID 34678403. https://pubmed.ncbi.nlm.nih.gov/34678403/
25. American College of Obstetricians and Gynecologists. Committee Opinion No. 762: Prepregnancy Counseling. Obstet Gynecol. 2019;133(1):e78–e89. doi:10.1097/AOG.0000000000003013. PMID 30575679. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/01/prepregnancy-counseling. Accessed 2026-08-15.
26. American College of Obstetricians and Gynecologists. Treatment and Management of Mental Health Conditions During Pregnancy and Postpartum: Clinical Practice Guideline No. 5. Obstet Gynecol. 2023;141(6):1262–1288. doi:10.1097/AOG.0000000000005202. PMID 37486661. https://pubmed.ncbi.nlm.nih.gov/37486661/
27. Robbins CL, et al. Timing of postpartum depressive symptoms. Prev Chronic Dis. 2023;20:230107. doi:10.5888/pcd20.230107. https://www.cdc.gov/pcd/issues/2023/23_0107.htm
28. Office of the U.S. Surgeon General. Parents Under Pressure: The U.S. Surgeon General’s Advisory on the Mental Health and Well-Being of Parents. 2024. PMID 39250580. https://www.ncbi.nlm.nih.gov/books/NBK606667/
29. World Health Organization. Guidelines on Mental Health at Work. 2022. ISBN 978-92-4-005305-2. https://www.who.int/publications/i/item/9789240053052. Accessed 2026-08-15.
30. Badawy Y, et al. The risk of depression in the menopausal stages: A systematic review and meta-analysis. J Affect Disord. 2024;357:126–133. doi:10.1016/j.jad.2024.04.041. PMID 38642901. https://pubmed.ncbi.nlm.nih.gov/38642901/
31. ESHRE, ASRM, CREWHIRL and IMS Guideline Group on POI; Panay N, Anderson RA, Bennie A, et al. Evidence-based guideline: premature ovarian insufficiency. Climacteric. 2024;27(6):510–520. doi:10.1080/13697137.2024.2423213. PMID 39647506. https://www.asrm.org/practice-guidance/practice-committee-documents/evidence-based-guideline-premature-ovarian-insufficiency—2024/. Accessed 2026-08-15.
32. U.S. Food and Drug Administration. FDA Approves Labeling Changes to Menopausal Hormone Therapy Products. February 12, 2026. https://www.fda.gov/news-events/press-announcements/fda-approves-labeling-changes-menopausal-hormone-therapy-products. Accessed 2026-08-15.
33. U.S. Food and Drug Administration. Menopausal Hormone Therapies with Updated Prescribing Information. February 12, 2026. https://www.fda.gov/drugs/drug-safety-and-availability/menopausal-hormone-therapies-updated-prescribing-information. Accessed 2026-08-15.
34. U.S. Preventive Services Task Force. Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions. 2022. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication. Accessed 2026-08-15.
35. Centers for Disease Control and Prevention. Health Effects of Social Isolation and Loneliness. https://www.cdc.gov/social-connectedness/risk-factors/index.html. Accessed 2026-08-15.
36. American Geriatrics Society 2023 Beers Criteria Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052–2081. doi:10.1111/jgs.18372. PMID 37139824. PMCID PMC12478568. https://pmc.ncbi.nlm.nih.gov/articles/PMC12478568/
37. National Institute on Alcohol Abuse and Alcoholism. Aging and Alcohol. https://www.niaaa.nih.gov/alcohols-effects-health/aging-and-alcohol. Accessed 2026-08-15.
38. National Institute on Aging. Memory Problems, Forgetfulness, and Aging. https://www.nia.nih.gov/health/memory-loss-and-forgetfulness/memory-problems-forgetfulness-and-aging. Accessed 2026-08-15.
39. U.S. Preventive Services Task Force. Cognitive Impairment in Older Adults: Screening. 2020. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cognitive-impairment-in-older-adults-screening. Accessed 2026-08-15.

If you or someone you know is in crisis

• Call 911 or go to your nearest emergency room for any life-threatening emergency.
• 988 Suicide & Crisis Lifeline — call or text 988, available 24/7. En español: marque 988 y oprima 2. Veterans: 988 and press 1, or text 838255.
• Crisis Text Line — text HOME to 741741.
• The Trevor Project (crisis support for LGBTQ+ young people) — call 1-866-488-7386, or text START to 678-678.
• National Sexual Assault Hotline (RAINN) — call 1-800-656-HOPE (4673) or text HOPE to 64673; free, confidential, 24/7. Online chat at RAINN.org/hotline.
• National Domestic Violence Hotline — call 1-800-799-SAFE (7233) or text START to 88788; 24/7, help in 200+ languages. Online chat at TheHotline.org. If your phone or computer may be monitored, calling from a safer device is an option.
• Riverside County — Inland SoCal Crisis Helpline 951-686-HELP (4357), 24/7 (Inland SoCal United Way / 211+, in partnership with RUHS-BH); Community Access, Referral, Evaluation and Support (CARES) Line 800-499-3008, 24/7.
• San Bernardino County — Access Unit (Behavioral Health Helpline) 888-743-1478, 24/7; Mobile Crisis/CCRT 800-398-0018 (24/7, all ages) or text 909-420-0560. Arrowhead Regional Medical Center (ARMC) has a dedicated walk-in adolescent psychiatric ER (ages 13–17).
• Children under 13 — call 911 for immediate danger, contact your county's mobile crisis team (they respond to all ages), or go to the nearest pediatric emergency room.
• California Peer-Run Warm Line (non-crisis — someone to talk to) — call or text 1-855-600-WARM (9276); daytime and evening hours, not a 24/7 line.
• NP Fady (non-emergency) — for routine scheduling or questions, call (909) 707-6261. This line is not monitored for emergencies.